Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        Risk adjusted net present value: What is the current valuation of Neurocrine Biosciences's NBI-1065846?
NBI-1065846 is a small molecule commercialized by Neurocrine Biosciences, with a leading Phase II program in Cognitive Impairment Associated With...
                                                Data Insights
                                                
                                        Risk adjusted net present value: What is the current valuation of Neurocrine Biosciences's NBI-1065846?
NBI-1065846 is a small molecule commercialized by Neurocrine Biosciences, with a leading Phase II program in Cognitive Impairment Associated With...
